tradingkey.logo

Insmed Inc

INSM

137.030USD

+1.440+1.06%
收盘 09/26, 16:00美东报价延迟15分钟
28.93B总市值
亏损市盈率 TTM

Insmed Inc

137.030

+1.440+1.06%
关于 公司
公司简介
公司代码INSM
公司名称Insmed Inc
上市日期Feb 15, 1991
CEOMr. William H. (Will) Lewis, J.D.
员工数量1271
证券类型Ordinary Share
年结日Feb 15
公司地址700 Us Highway 202/206
城市BRIDGEWATER
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编08807
电话19089779900
网址https://insmed.com/
公司代码INSM
上市日期Feb 15, 1991
CEOMr. William H. (Will) Lewis, J.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. William H. (Will) Lewis, J.D.
Mr. William H. (Will) Lewis, J.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
402.00K
-2.59%
Dr. Melvin A. Sharoky, M.D.
Dr. Melvin A. Sharoky, M.D.
Independent Director
Independent Director
308.40K
-3.70%
Mr. David R. Brennan
Mr. David R. Brennan
Lead Independent Director
Lead Independent Director
113.77K
+4.65%
Dr. Clarissa Desjardins, Ph.D.
Dr. Clarissa Desjardins, Ph.D.
Independent Director
Independent Director
53.84K
+10.37%
Ms. Carol Anne Schafer
Ms. Carol Anne Schafer
Independent Director
Independent Director
50.16K
+11.22%
Mr. Roger Adsett
Mr. Roger Adsett
Chief Operating Officer
Chief Operating Officer
25.55K
-49.45%
Dr. Martina Flammer, M.D.
Dr. Martina Flammer, M.D.
Chief Medical Officer
Chief Medical Officer
4.27K
-66.30%
Ms. Sara M. Bonstein
Ms. Sara M. Bonstein
Chief Financial Officer
Chief Financial Officer
239.00
-98.89%
Mr. Leo Lee
Mr. Leo Lee
Independent Director
Independent Director
--
--
Mr. Bryan Dunn
Mr. Bryan Dunn
Vice President, Investor Relations
Vice President, Investor Relations
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. William H. (Will) Lewis, J.D.
Mr. William H. (Will) Lewis, J.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
402.00K
-2.59%
Dr. Melvin A. Sharoky, M.D.
Dr. Melvin A. Sharoky, M.D.
Independent Director
Independent Director
308.40K
-3.70%
Mr. David R. Brennan
Mr. David R. Brennan
Lead Independent Director
Lead Independent Director
113.77K
+4.65%
Dr. Clarissa Desjardins, Ph.D.
Dr. Clarissa Desjardins, Ph.D.
Independent Director
Independent Director
53.84K
+10.37%
Ms. Carol Anne Schafer
Ms. Carol Anne Schafer
Independent Director
Independent Director
50.16K
+11.22%
Mr. Roger Adsett
Mr. Roger Adsett
Chief Operating Officer
Chief Operating Officer
25.55K
-49.45%
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
暂无数据
地区USD
名称
营收
占比
US
64.28M
69.24%
Japan
22.08M
23.79%
Europe and rest of worldld
6.46M
6.96%
业务
地区
暂无数据
股东统计
更新时间: 9月5日 周五
更新时间: 9月5日 周五
持股股东
股东类型
持股股东
持股股东
占比
Darwin Global Management Ltd
9.15%
The Vanguard Group, Inc.
8.33%
JP Morgan Asset Management
6.14%
T. Rowe Price Associates, Inc.
5.24%
BlackRock Institutional Trust Company, N.A.
4.26%
其他
66.88%
持股股东
持股股东
占比
Darwin Global Management Ltd
9.15%
The Vanguard Group, Inc.
8.33%
JP Morgan Asset Management
6.14%
T. Rowe Price Associates, Inc.
5.24%
BlackRock Institutional Trust Company, N.A.
4.26%
其他
66.88%
股东类型
持股股东
占比
Investment Advisor
44.44%
Hedge Fund
26.91%
Investment Advisor/Hedge Fund
22.20%
Research Firm
2.99%
Family Office
1.09%
Bank and Trust
0.92%
Sovereign Wealth Fund
0.92%
Pension Fund
0.85%
Individual Investor
0.67%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
807
207.14M
108.81%
-3.07M
2025Q1
804
211.64M
111.66%
-239.74K
2024Q4
767
205.04M
113.32%
-2.57M
2024Q3
712
200.94M
112.58%
+1.71M
2024Q2
657
186.57M
112.00%
+21.58M
2024Q1
564
156.59M
105.42%
-6.86M
2023Q4
544
155.47M
105.16%
-6.81M
2023Q3
515
153.95M
107.69%
-8.46M
2023Q2
506
152.37M
106.87%
-10.75M
2023Q1
511
151.28M
110.90%
-8.90M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Darwin Global Management Ltd
15.40M
8.12%
+2.44M
+18.81%
Mar 31, 2025
The Vanguard Group, Inc.
18.23M
9.61%
+47.77K
+0.26%
Mar 31, 2025
JP Morgan Asset Management
5.41M
2.85%
+2.51M
+86.84%
Mar 31, 2025
T. Rowe Price Associates, Inc.
12.76M
6.73%
+212.23K
+1.69%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
13.00M
6.85%
-170.21K
-1.29%
Mar 31, 2025
Baker Bros. Advisors LP
5.38M
2.84%
+373.76K
+7.47%
Mar 31, 2025
Capital International Investors
7.20M
3.79%
+81.49K
+1.14%
Mar 31, 2025
Fidelity Management & Research Company LLC
3.34M
1.76%
-1.33M
-28.48%
Mar 31, 2025
State Street Global Advisors (US)
5.75M
3.03%
-358.86K
-5.88%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
Invesco Dorsey Wright Healthcare Momentum ETF
5.42%
BNY Mellon Innovators ETF
3.76%
VanEck Biotech ETF
3.65%
Franklin Genomic Advancements ETF
3.46%
SPDR S&P Biotech ETF
2.5%
ProShares Ultra Nasdaq Biotechnology
2.04%
Invesco Nasdaq Biotechnology ETF
2.04%
Virtus LifeSci Biotech Products ETF
2%
iShares Biotechnology ETF
1.86%
Direxion Daily S&P Biotech Bull 3X Shares
1.43%
查看更多
Invesco Dorsey Wright Healthcare Momentum ETF
占比5.42%
BNY Mellon Innovators ETF
占比3.76%
VanEck Biotech ETF
占比3.65%
Franklin Genomic Advancements ETF
占比3.46%
SPDR S&P Biotech ETF
占比2.5%
ProShares Ultra Nasdaq Biotechnology
占比2.04%
Invesco Nasdaq Biotechnology ETF
占比2.04%
Virtus LifeSci Biotech Products ETF
占比2%
iShares Biotechnology ETF
占比1.86%
Direxion Daily S&P Biotech Bull 3X Shares
占比1.43%
分红派息
近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
KeyAI